• FirefoxUpgrade to the new Firefox »
  •  Dow Down0.79% Nasdaq Up0.16%

    Anthera Pharmaceuticals, Inc. (ANTH)

    -NasdaqGM
    2.07 0.03(1.43%) Jan 23, 3:59PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development5,268  5,279  5,765  7,439  
    Selling General and Administrative1,419  1,586  1,844  1,433  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (6,687) (6,865) (7,609) (8,872)
    Income from Continuing Operations
    Total Other Income/Expenses Net(14)(31)(48)(48)
    Earnings Before Interest And Taxes(6,701)(6,896)(7,657)(8,920)
    Interest Expense286  360  259  277  
    Income Before Tax(6,987)(7,256)(7,916)(9,197)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(6,987)(7,256)(7,916)(9,197)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (6,987) (7,256) (7,916) (9,197)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (6,987) (7,256) (7,916) (9,197)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.